Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Rashtriya Janata Dal national president Lalu Prasad Yadav's elder son, Bihar's former minister in
One after another happiness is knocking at Abhishek Malhan's house. First, he won season 1 of Bat
Bigg Boss 19: 'Baklava' is just an excuse Is this the reason why Tanya Mittal visits Dubai?
'You can love her, you can hate her, but you can't ignore her...', this is the condition of Tanya
Heavy rains and landslides have caused devastation all around in Wayanad. So far, more than 300 p
Good news for Stranger Things fans! The wait is over. The much-awaited Season 5 has been released
The general budget is being discussed in the Rajya Sabha today. However, opposition leaders belie
Actor Ranvir Shorey is currently seen in Bigg Boss OTT 3. In the show, he is seen talking about h
All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi has warned the government o
Amidst the Lok Sabha elections, the BJP is continuously accusing Congress that in Congress-r
SIIMA 2024: After winning the award, Aishwarya said- It means a lot, my guru directed the film
Aishwarya Rai won the Best Actress (Critics) award in the lead role at the South Indian Internati
